Brigatinib decreases the size of NF2-related progressive tumors
1. In this randomized controlled trial, brigatinib reduced the size of progressively growing tumors in patients with neurofibromatosis type 2-related ...
Tag: NF2-SWN
1. In this randomized controlled trial, brigatinib reduced the size of progressively growing tumors in patients with neurofibromatosis type 2-related ...